4/15
02:36 am
hkmpy
With 52% institutional ownership, Hikma Pharmaceuticals PLC (LON:HIK) is a favorite amongst the big guns [Yahoo! Finance]
Neutral
Report
With 52% institutional ownership, Hikma Pharmaceuticals PLC (LON:HIK) is a favorite amongst the big guns [Yahoo! Finance]
3/6
08:10 pm
hkmpy
Rakuten Medical Closes $119 Million Series E Financing to Further Develop its Alluminox™ Platform [Yahoo! Finance]
Low
Report
Rakuten Medical Closes $119 Million Series E Financing to Further Develop its Alluminox™ Platform [Yahoo! Finance]
2/27
12:09 pm
hkmpy
Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada [Yahoo! Finance]
Neutral
Report
Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada [Yahoo! Finance]
2/26
06:01 pm
hkmpy
Merck's Bridion faces generic threat from drugmaker Hikma [Reuters]
Neutral
Report
Merck's Bridion faces generic threat from drugmaker Hikma [Reuters]
2/26
05:56 pm
hkmpy
Merck's Bridion faces generic threat from drugmaker Hikma [Yahoo! Finance]
Neutral
Report
Merck's Bridion faces generic threat from drugmaker Hikma [Yahoo! Finance]
2/21
01:20 pm
hkmpy
Hikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus, Ohio manufacturing facility
Neutral
Report
Hikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus, Ohio manufacturing facility
1/29
09:42 am
hkmpy
Hikma Pharmaceuticals PLC's (LON:HIK) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? [Yahoo! Finance]
Low
Report
Hikma Pharmaceuticals PLC's (LON:HIK) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? [Yahoo! Finance]